🔗 Permalink

Inventor profile of:

Dan Wang

City:

Worcester, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2026-05-21

Top Assignees for applications by Dan Wang

The entities that hold a legal rights for patent applications filed by inventor Wang Dan:

UNIVERSITY OF MASSACHUSETTS 9 Boston, MA United States
UNIVERSITY OF MASSACHUSETTS 9 Westborough, MA United States
The Clinic for Special Children, Inc 5 Strasburg, PA United States
Clinic for Special Children 2 Strasburg, PA United States

Recent patent applications by Wang Dan

Dan Wang from Worcester, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-21

US20260139249A1

Chemistry; metallurgy

GENE REPLACEMENT THERAPY FOR FOXG1 SYNDROME

#2 | 2026-03-05

US20260062682A1

Chemistry; metallurgy

AAV-MEDIATED GENE THERAPY FOR MAPLE SYRUP URINE DISEASE (MSUD)

#3 | 2025-10-16

US20250320524A1

Chemistry; metallurgy

EFFECTIVELY PACKAGING HIGH-QUALITY RAAV VECTORS BY MINICIRCLE DUAL TRANSFECTION

#4 | 2025-10-16

US20250320256A1

Chemistry; metallurgy

AAV5 CAPSID WITH NON-CANONICAL AMINO ACID INCORPORATION AND USES THEREOF

#5 | 2025-06-12

US20250188490A1

Chemistry; metallurgy

METHODS OF RAAV PACKAGING

#6 | 2025-05-29

US20250170274A1

Human necessities

GENE THERAPEUTICS FOR TREATING BONE DISORDERS

#7 | 2024-07-04

US20240216542A1

Human necessities

GM3 SYNTHASE VECTORS AND USES THEREOF

#8 | 2024-06-27

US20240207370A1

Human necessities

GENE THERAPY FOR BCAA MODULATION IN MAPLE SYRUP URINE DISEASE (MSUD)

#9 | 2023-12-28

US20230416779A1

Chemistry; metallurgy

SELF-REGULATING AAV VECTORS FOR SAFE EXPRESSION OF MECP2 IN RETT SYNDROME

#10 | 2023-05-18

US20230151359A1

Chemistry; metallurgy

GENE REPLACEMENT THERAPY FOR FOXG1 SYNDROME

#11 | 2022-05-26

US20220162571A1

Chemistry; metallurgy

GM3 SYNTHASE VECTORS AND USES THEREOF

#12 | 2022-05-26

US20220162570A1

Chemistry; metallurgy

AAV-MEDIATED GENE THERAPY FOR MAPLE SYRUP URINE DISEASE (MSUD)

#13 | 2021-01-28

US20210023241A1

Human necessities

Gene therapeutics for treating bone disorders

#14 | 2020-07-23

US20200231953A1

Chemistry; metallurgy

Compositions and methods for transient delivery of nucleases

InventorID:

5946895 ⎘